Affiliation:
1. Amity Institute of Public Health, Amity University, Noida 201303, India
2. The Union South East Asia Office, New Delhi 110016, India
Abstract
More than half of the people with TB in India seek care from the private sector, where suboptimal quality of care is a concern. Significant progress has been made over the last five years to expand the coverage and to involve more private sector providers in TB care under the National TB Elimination Program (NTEP) in India. The objective of this review is to describe the major efforts and the progress made with regard to the engagement of the ‘for-profit’ private health service delivery sector for TB care in India, to critically discuss this, and to suggest the way forward. We described the recent efforts by the NTEP for private sector engagement based on the literature, including strategy documents, guidelines, annual reports, evaluation studies, and critically looked at the strategies against the vision of partnership. The NTEP has taken a variety of approaches, including education, regulation, provision of cost-free TB services, incentives, and partnership schemes to engage the private sector. As a result of all these interventions, private sector contribution has increased substantially, including TB notification, follow-up, and treatment success. However, these still fall short of achieving the set targets. Strategies were focused more towards the purchase of services rather than creating sustainable partnerships. There are no major strategies to engage the diverse set of providers, including informal health care providers and chemists, who are the first point of contact for a significant number of people with TB. India needs an integrated private sector engagement policy focusing on ensuring standards of TB care for every citizen. The NTEP should adopt an approach specifically tailored to the various categories of providers. For meaningful inclusion of the private sector, it is also essential to build understanding and generate data intelligence for better decision making, strengthen the platforms for engagement, and expand the social insurance coverage.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Immunology and Microbiology
Reference49 articles.
1. World Health Organisation (2023, January 10). Global TB Report 2022. WHO. Available online: https://www.who.int/teams/global-tuberculosis-programme/tb-reports.
2. Government of India. Ministry of Health and Family Welfare (MOHFW) (2023, January 10). Central TB Division. National Strategic Plan for Tuberculosis Elimination 2017–2025. MOHFW, Available online: https://tbcindia.gov.in/WriteReadData/NSP%20Draft%2020.02.2017%201.pdf.
3. Indian Council of Medical Research (2022, January 10). National TB Prevalence Survey 2019–2021. ICMR, Available online: https://tbcindia.gov.in/showfile.php?lid=3659.
4. The number of privately treated tuberculosis cases in India: An estimation from drug sales data;Arinaminpathy;Lancet Infect. Dis.,2016
5. Arinaminpathy, N., Batra, D., and Maheshwari, N. (2019). Tuberculosis treatment in the private healthcare sector in India: An analysis of recent trends and volumes using drug sales data. BMC Infect. Dis., 19.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献